Abbott Laboratories (ABT) This autumn 2024 Earnings Name Transcript


Abbott Laboratories (NYSE:ABT) This autumn 2024 Earnings Convention Name January 22, 2025 9:30 AM ET

Firm Individuals

Mike Comilla – Vice President, Investor Relations
Robert Ford – Chairman & Chief Govt Officer
Phil Boudreau – Govt Vice President, Finance & Chief Monetary Officer

Convention Name Individuals

Robbie Marcus – JPMorgan
Larry Biegelsen – Wells Fargo
Travis Steed – BofA Securities
Vijay Kumar – Evercore ISI
Josh Jennings – TD Cowen
David Roman – Goldman Sachs
Joanne Wuensch – Citi
Danielle Antalffy – UBS
Matt Miksic – Barclays

Operator

Good morning and thanks for standing by. Welcome to Abbott’s Fourth Quarter 2024 Earnings Convention Name. All contributors will be capable of hear solely till the question-and-answer portion of this name. [Operator Instructions] This name is being recorded by Abbott. Apart from any participant’s questions requested through the question-and-answer session, your entire name, together with the question-and-answer session, is materials copyrighted by Abbott. It can’t be recorded or rebroadcast with out Abbott’s categorical written permission.

I might now wish to introduce Mr. Mike Comilla, Vice President, Investor Relations.

Mike Comilla

Good morning and thanks for becoming a member of us. With me at this time are Robert Ford, Chairman and Chief Govt Officer; and Phil Boudreau, Govt Vice President, Finance and Chief Monetary Officer. Robert and Phil will present opening remarks. Following their feedback, we’ll take your questions.

Earlier than we get began, some statements made at this time could also be forward-looking for functions of the Non-public Securities Litigation Reform Act of 1995, together with the anticipated monetary outcomes for 2025. Abbott cautions that these forward-looking statements are topic to dangers and uncertainties that will trigger precise outcomes to vary materially from these indicated within the forward-looking statements. Financial, aggressive, governmental, technological, and different components that will have an effect on Abbott’s operations are mentioned in Merchandise 1A, Threat Elements, to our annual report on Type 10-Ok for the year-ended December 31, 2023. Abbott undertakes



Source link

Related articles

Twister Money developer calls his lawsuit a ‘terrifying criminalization of privateness’

Roman Storm, co-founder of Twister Money, described his prosecution in a Jan. 22 X submit as a “terrifying criminalization of privateness.” Twister Money is a non-custodial privateness protocol facilitating personal crypto transactions by...

Trump threatens Russia with tariffs if Putin does not settle warfare

Excessive danger warning: Overseas alternate buying and selling carries a excessive stage of danger that might not...

J&J beats quarterly gross sales and revenue estimates on most cancers drug gross sales By Reuters

By Patrick Wingrove and Bhanvi Satija (Reuters) - Johnson & Johnson (NYSE:), contemporary off a $14.6 billion deal to purchase neurological drugmaker Intra-Mobile, reported fourth-quarter gross sales and revenue above Wall Road...

Meta’s Oakley smartglasses could possibly be the following huge wearable trendsetter

The Ray-Ban Meta smartglasses are only the start for Meta, if a brand new report detailing the corporate’s {hardware} plan for the approaching 12 months is correct. Meta apparently has a number of...

Pure Fuel: Close to-Time period Bearishness May Persist With $3.70 Assist Below Menace

Shifting climate patterns, EIA projections sign a difficult short-term outlook for pure fuel. International demand and the vitality transition spotlight a bullish case for the years forward. Key help ranges close to $3.70 may decide...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com